Arbutus Biopharma Corp (ABUS): Bathi resik saben saham sajrone 12 wulan pungkasan

Simbol lan logo merek Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma (ABUS) develops high-margin hepatitis B drugs with global market potential. The 12-month EPS trend on this GURU.Markets chart demonstrates financial resilience, while the 1.12 metric confirms current levels. The business model relies on outsourced manufacturing to minimize capital expenditures. Market confidence is sustained by a reputable management team that effectively protects intellectual property.

ABUS (Arbutus Biopharma) riwayat Bathi resik saben siji saham sajrone rolas wulan pungkasan saka 04.07.2022 nganti 15.11.2026

Ringkesan rincian data analitis Tekmira Pharmaceuticals (ABUS)

- rega saham lan target rega konsensus:
Rega saham Arbutus Biopharma Corp|ABUS - Target median analis
- data kapitalisasi bursa:
Biji pasar Arbutus|ABUS - Nilai Total Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Buku saben Saham Arbutus Biopharma|ABUS - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku arbutusbio.com|ABUS - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Arbutus Biopharma|ABUS - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Arbutus Biopharma|ABUS - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Arbutus|ABUS - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Arbutus Biopharma|Indikator likuiditas cepet arbutusbio.com
- indikator pendapatan resik lan kelipatan nilai:
ABUS - Bathi sawise mbayar pajeg|Bathi mangsa ngarep Arbutus Biopharma|ABUS - Pangali P/E|Rega marang bathi mangsa ngarep Tekmira Pharmaceuticals|ABUS - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Tekmira Pharmaceuticals|ABUS - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Arbutus Biopharma|ABUS - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan arbutusbio.com|ABUS - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Arbutus Biopharma
- data pendapatan lan penerimaan dodolan:
ABUS - Total pendapatan perusahaan|Prakiraan pendapatan perusahaan Arbutus Biopharma|ABUS - Rasio rega marang dodolan|Multiplikator Forward P/S Tekmira Pharmaceuticals|ABUS - Dinamika pendapatan YoY sajrone rolas wulan kepungkur
Analisis umum perusahaan:Arbutus Biopharma Corporation (ABUS)
Produk sing diprodhuksi Arbutus

The investment attractiveness of Arbutus Biopharma (ABUS) is based on the scientific value of its RNA platform for hepatitis B therapy, making the monitoring of real business returns critically important. Analyzing this 12-month net income per share chart, an investor can see the final profit distributed per share, which allows for an assessment of capital efficiency regardless of share dilution and determines the fundamental stability of the company.

Analisis pesaing Arbutus Biopharma

Arrowhead Pharma - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone patang kuartal pungkasan Mirum Pharma MIRM|DVAX (Dynavax Technologies) - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi resik saben siji saham sajrone rolas wulan pungkasan Inventiva Corp (IVA)|GYRE (Gyre Therapeutics Inc) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan assemblybio.com ASMB|Bathi saben saham sajrone rolas wulan pungkasan Galectin Therapeutics, Inc. (GALT)|GNFT (GENFIT) - Bathi saben saham sajroning taun lumaku|Bathi resik saben saham (EPS TTM) DRRX (durect.com)|Bathi resik saben saham (EPS TTM) Aligos Therapeutics ALGS|BioVie Inc - Bathi resik saben saham (EPS TTM)|GLMD - Bathi resik saben saham (EPS TTM)|NDRA: Bathi resik saben saham (EPS TTM)|Bathi saben siji saham sajrone 12 wulan pungkasan HEPA (Hepion Pharmaceuticals Inc.)